Well Controlled Severe Allergic Asthma clinical trials

Explore recruiting well controlled severe allergic asthma clinical trials.

Recruiting well controlled severe allergic asthma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Well Controlled Severe Allergic Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SHORTEN - Impact of omalizumab withdrawal after a 3 year duration treatment in well controlled severe allergic asthma : a multicentric randomized controlled trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Well Controlled Severe Allergic Asthma trials by city

Well Controlled Severe Allergic Asthma in Toronto Well Controlled Severe Allergic Asthma in Vancouver Well Controlled Severe Allergic Asthma in Montreal Well Controlled Severe Allergic Asthma in Calgary Well Controlled Severe Allergic Asthma in Edmonton Well Controlled Severe Allergic Asthma in Ottawa Well Controlled Severe Allergic Asthma in Winnipeg Well Controlled Severe Allergic Asthma in Quebec City Well Controlled Severe Allergic Asthma in Hamilton Well Controlled Severe Allergic Asthma in Kitchener Well Controlled Severe Allergic Asthma in London Well Controlled Severe Allergic Asthma in Halifax Well Controlled Severe Allergic Asthma in New York Well Controlled Severe Allergic Asthma in Los Angeles Well Controlled Severe Allergic Asthma in Chicago Well Controlled Severe Allergic Asthma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease